Incanthera Therapeutics Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

Incanthera Therapeutics General Information

Description

Developer of anti-cancer drugs designed for the treatment of cancer. The company caters to the healthcare industry and specializes in developing prodrugs for the treatment of cancer.

Contact Information

Formerly Known As
Almin, Spear Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 76 King Street King Street
  • Manchester M2 4NH
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 76 King Street King Street
  • Manchester M2 4NH
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Incanthera Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Incanthera Therapeutics‘s full profile, request access.

Request a free trial

Incanthera Therapeutics Patents

Incanthera Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2009254176-A1 4, 6-diphenylpyrid-2-0nes against cancer Inactive 04-Jun-2008
WO-2009146910-A1 4, 6-diphenylpyrid-2-0nes against cancer Inactive 04-Jun-2008
WO-2009146910-A8 4, 6-diphenylpyrid-2-0nes against cancer Inactive 04-Jun-2008
EP-2310370-A1 4, 6-diphenylpyrid-2-ones against cancer Inactive 04-Jun-2008
JP-2011521986-A 4,6-diphenylpyrid-2-one for cancer Pending 04-Jun-2008 C07D213/64
To view Incanthera Therapeutics’s complete patent history, request access »

Incanthera Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Incanthera Therapeutics‘s full profile, request access.

Request a free trial

Incanthera Therapeutics FAQs

  • When was Incanthera Therapeutics founded?

    Incanthera Therapeutics was founded in 2002.

  • Where is Incanthera Therapeutics headquartered?

    Incanthera Therapeutics is headquartered in Manchester, United Kingdom.

  • What industry is Incanthera Therapeutics in?

    Incanthera Therapeutics’s primary industry is Drug Discovery.

  • Is Incanthera Therapeutics a private or public company?

    Incanthera Therapeutics is a Private company.

  • What is Incanthera Therapeutics’s current revenue?

    The current revenue for Incanthera Therapeutics is .

  • How much funding has Incanthera Therapeutics raised over time?

    Incanthera Therapeutics has raised $8.5M.

  • Who are Incanthera Therapeutics’s investors?

    Advent International, Bloomsbury Bioseed Fund, Cancer Research Technology, De Montfort University Endowment, and Synthesis Capital (Boston) have invested in Incanthera Therapeutics.

  • When was Incanthera Therapeutics acquired?

    Incanthera Therapeutics was acquired on 28-Jan-2015.

  • Who acquired Incanthera Therapeutics?

    Incanthera Therapeutics was acquired by Incanthera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process